FDA Names 4 Center Directors as Psychedelics Reviews Take Shape
The FDA's new permanent CDER director is Michael Davis, whose psychiatric drug and psychedelic nonprofit background aligns with White House calls for faster psilocybin, MDMA, and LSD reviews. Vaccine and tobacco center leadership also stabilized.